Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.34 |
| ▸ | PRKDC | P78527 | 5/20 | 0.34 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25536091 | 0.96 | ALOX5 (0.41) | ALOX5PARP14PRKDCLIMK1PIK3CD | |
| SCHEMBL25535743 | 0.96 | ALOX5 (0.44) | ALOX5PARP14PRKDCLIMK1 | |
| SCHEMBL25535749 | 0.94 | ALOX5 (0.42) | ALOX5PARP14PRKDCLIMK1 | |
| SCHEMBL24964442 | 0.94 | ALOX5 (0.40) | ALOX5PARP14PRKDCPIK3CDPIK3CB | |
| SCHEMBL25558594 | 0.94 | ALOX5 (0.42) | ALOX5PARP14PRKDCBRDT | |
| SCHEMBL25558504 | 0.92 | BRDT (0.33) | ALOX5LIMK1BRDT | |
| SCHEMBL25536410 | 0.92 | ALOX5 (0.48) | ALOX5PARP14PRKDCPIK3CDPIK3CB | |
| SCHEMBL25555389 | 0.92 | ALOX5 (0.42) | ALOX5PARP14PRKDC | |
| SCHEMBL25534968 | 0.92 | ALOX5 (0.43) | ALOX5PARP14PRKDCLIMK1 | |
| SCHEMBL24965443 | 0.92 | ALOX5 (0.40) | ALOX5PARP14PRKDCPIK3CDPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172058-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-01 | — | — | US | disclosed |
| US-20230172058-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172058-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | LEF1, PIEZO1, ELAVL1 | ALOX5 845/4885PARP14 4560/4885PRKDC 4598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.